Home
About us
Site map
Contacts
Technology (PDF)
Corporate (PDF)
Influenza (PDF)
APC Presentation (PPT)
VAXINNATE in NEWS
12/1-12/2/2010
London, EUROPE
Vaccines Europe 2010
Join us for 2010's Vaccines Europe, set to be Informa's best yet!
Read more
11/9-11/11/2010
Washington, DC
Influenza Congress USA – Washington DC
Commercial development and investment opportunities in influenza vaccines and antivirals
Read more
11/2-11/4/2010
Boston, USA
Top 10 Most interesting Infectious Diseases Projects to Watch;
Dr. Becker Presented – Received award
Read more
9/3-9/7/2010
Hong Kong SAR
Options for the Control of Influenza VII;
More than 1,400 Researchers from all corners of the globe convened in Hong Kong, SAR, China for Options for the Control of Influenza VII.
Read more
VaxInnate in News
12/19/2011
VaxInnate Licenses Recombinant Flu Vaccines
To CJ CheilJedang Corporation of South Korea.
04/21/2011
U.S. Congressman Rush Holt Visits VaxInnate
Lauds Government Funding for Development of Modern Flu Vaccines.
03/01/2011
VaxInnate Awarded Contract by the U.S. Government
Potential value of contract as high as $196 million
02/28/2011
HHS awards contracts to develop new flu vaccine technology- VaxInnate
VaxInnate received a HHS contract for the development
11/01/2010
VaxInnate's Novel Recombinant Flu Vaccine Named a Top 110 Biopharma Project to watch in 2011
Vax125 was selected by an expert panel
04/27/2010
VaxInnate's VAX125 Seasonal Flu Vaccine Shown Safe and Highly Immunogenic in Phase II Study of Elderly Subjects;
We should be able to provide a much-needed new option for protecting the elderly against seasonal flu
03/18/2010
Hofstaetter named President and CEO; Shaw names CSO and Chairman;
We're pleased that Thomas Hofstaetter has agreed to lead VaxInnate as we begin a new chapter
01/12/2010
VaxInnate Licenses Recombinant H1N1 Pandemic Swine Flu Vaccine to Biological E.;
Vaccine Could Become Available for Use in India This Year
Read more
©2011 VaxInnate, Inc. |
Legal
|
Privacy